Developments include Roche and Genentech rolling out phenomaps, a partnership between Gibson and MIT, an MIT/Nvidia platform collaboration, and a Sanofi milestone achievement.
2 reports, 2 independent
Updated Jun 19
Gone quiet
- Reports
- 2
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Developments include Roche and Genentech rolling out phenomaps, a partnership between Gibson and MIT, an MIT/Nvidia platform collaboration, and a Sanofi milestone achievement.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Sanofi appointed Paulo Fontoura, who previously served as CMO of Xaira Therapeutics, as Global Head of R&D.Sub-event
- A new AI biology venture, co-founded by Patrick Collison, is competing in the AI drug discovery market.Sub-event
Concurrent developments involving phenomaps, MIT partnerships, and Sanofi milestone achievements.1 source
Keep exploring
The entities involved
-
Hoffmann-La Roche
Swiss healthcare company
-
Sanofi
company in Milan, Italy
Nothing else this week.
-
MIT
company in the Czech Republic
Related events
Coverage
Newest first; wire copies grouped- yahoo.com
- GuruFocus.comRecursion Sets $100 Million Partnership Goal by 202 Recursion (NASDAQ:RXRX) just laid out a roadmap that balances science and cash, and it looks promising. CEO Christopher Gibson talked up how the Ex